Back to search
FDAFDA · Food and drugs·Recall number D-1053-2014

Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, 100 count bottles, Rx only. Manufactured by Watson Laboratories, Inc., Corona, CA 92880. Distributed by: Watson Pharma, Inc. NDC: 00591-0517-01.

Published February 5, 2014 · Recall initiated: January 15, 2014

Summary

FDA records drug Class II recall D-1053-2014, published February 5, 2014 and initiated January 15, 2014. Recalling firm: Watson Laboratories Inc; Status: Terminated; Reported quantity: 717 bottles; Lot: Lot #: 697316A, Expiry: Mar 2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications; Product contains broken tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Watson Laboratories Inc
Distributor
Nationally in: AZ, CA, CT, FL, NV, OH, OK, PA, SC, WI.
Lot
Lot #: 697316A, Expiry: Mar 2015.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, 100 count bottles, Rx only. Manufactured by Watson Laboratories, Inc., Corona, CA 92880. Distributed by: Watson Pharma, Inc. NDC: 00591-0517-01. recalled?

Yes. FDA published recall D-1053-2014 on February 5, 2014. Reported hazard: Failed Tablet/Capsule Specifications; Product contains broken tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter